We report on a girl, born to first cousin Lebanese parents, with intellectual disability, seizures, repeated gingivorrhagia, enlarged lower and upper jaws, overgrowth of the gums, high arched and narrow palate, crowded teeth, hirsutism of the back, large abdomen and a small umbilical hernia. Cysts of the mandible, fibrous dysplasia of bones, and enlarged adenoids causing around 60% narrowing of the nasopharyngeal airways were noted at radiographic examination. Her brother presented with the same features in addition to a short stature, an ostium secundum, and more pronounced intellectual disability. He died at the age of 8 years from a severe pulmo- 
| INTRODUCTION
Ramon syndrome (OMIM 266270) is a rare entity characterized by the presence of cherubism, gingival fibromatosis, epilepsy, intellectual disability, hypertrichosis, and short stature. Since its first description by Ramon et al in 1967 , 1 2 other families have been described. [2] [3] [4] Here, we report on a new family with Ramon syndrome. Whole exome sequencing (WES) revealed the presence of a novel homozygous mutation in ELMO2. Review of the literature and differential diagnosis are discussed.
Parkin and Law reported follow-up of 2 sibs with Ramon syn- Some of the features of Ramon syndrome are found in patients treated with phenytoin. Gingival hyperplasia also occurs in the Rutherfurd syndrome (180900), the Laband syndrome (135500), and the Jones syndrome (135550).
| MATERIALS AND METHODS

| Patients
The proband, a girl, is issued from a consanguineous Lebanese family.
She underwent a work-up including a thorough clinical evaluation, total body X-rays, echocardiography, karyotype, and routine blood tests (complete blood count, serum electrolytes, blood glucose levels, cholesterol, thyroid, liver and renal function tests, and phosphatase alkaline levels).
| Molecular analysis 2.2.1 | DNA isolation
Informed consent for genetic analysis was obtained from the family in compliance with national ethics regulation. Genomic DNA was isolated from the parents and the patient blood samples, and from cordal cord of 1 deceased child using standard techniques.
| Genome-wide microarray CGH analysis
Comparative Genome Hybridization (CGH) was carried out with the Affymetrix Cytogenetics Whole-Genome 2.7M Array (Affymetrix, Santa Clara, CA) following the manufacturers' standard protocol. Data were collected using GeneChip Scanner 3000 7G and CEL files were analyzed using Affymetrix Chromosome Analysis Suite software, Affymetrix, Santa Clara, CA (ChAS v.1.0.1).
| Whole exome sequencing
WES was carried out on the affected girl. Library preparation, exome capture and sequencing were performed as described earlier. 5, 6 Briefly, exomes were enriched using a SOLiD-optimized SureSelect human exome kit (Agilent v4, 50 Mb, Agilent Technologies Inc., Santa Clara, California), followed by sequencing performed using the 5500xl platform (Life Technologies, Carlsbad, California) with 82-fold average coverage. Sequence reads were mapped to the reference human genome (hg19) using LifeScope v2.1 (Life Technologies). Variants were called using high stringency settings and annotated with an inhouse pipeline 7 containing information from dbSNP138, ExAC (http://exac.broadinstitute.org/) and >15 000 exomes run in-house.
We only selected variants affecting coding exons or canonical splice sites. Subsequently, synonymous variants were filtered out, and only rare variants (frequency of <0.1% in both dbSNP138 and our inhouse database containing >15 000 exomes) with high quality were reported (Table S1 in Appendix S1, Supporting information). Considering autosomal recessive inheritance and consanguinity, we assumed identity by descent and thus selected homozygous variants (Table S2 in Appendix S1).
3 | RESULTS
| Clinical report
The proband is the second child of a healthy G5P2A1 mother. Her parents are first degree consanguineous, and at the time of birth, the mother's age was 29 years and the father's was 40 years.
She was born at term at 39 weeks of gestation by C-section after an unremarkable pregnancy. Her birth weight was 3100 g (50th percentile), her length was 50 cm (65th percentile), and her head circumference (OFC) was 35 cm (50th percentile). Developmental milestones were within normal limits. At the age of 3 months she had some oozing from her gums which was not investigated. At around the age of 10 months, her parents noted an abnormal shape of the mandible and an accentuation of the flatness of the nasal bridge.
She was first seen at the age of 2.5 years ( Figure 1A ). The major complaints of the parents were the persistence of a gingivorrhagia and the intellectual disability. Height was 91 cm (35th percentile), weight 12 kg (25th percentile), and OFC 50.7 cm (75th percentile).
There were enlarged lower and upper jaws, overgrowth of the gums, high arched and narrow palate, ectopic tooth eruption, hirsutism of the back, prominent abdomen, a small umbilical hernia and She had a brother who presented with similar but milder features in addition to an ostium secundum, a strabismus and more pronounced intellectual disability ( Figure 1D ). He died at the age of 8 years from a severe pulmonary infection and repeated bleeding episodes.
Clinical examination of the parents was normal.
| Molecular studies
Array-CGH analysis for submicroscopic deletions/duplications revealed no causal CNVs in the patient.
Among all the variants detected by WES, only 4 homozygous variants remained after applying the filters, as detailed above. This included variants in SSPO, BAG5, CHD6 and ELMO2. The only private variant that was never observed before was the variant in ELMO2 (Table S2 in Appendix S1). Interestingly, the variants in ELMO2 and The ELMO2 mutation is absent in a set of 210 Lebanese control chromosomes and in the EXAC database. The variation is very conserved among species and is predicted to be probably damaging by PolyPhen and SIFT.
| DISCUSSION
Here, we report on a consanguineous Lebanese family where 2 sibs present with Ramon syndrome. By WES, a pathogenic mutation in ELMO2 encoding engulfment and cell motility protein 2 was identified.
Recently, loss of function mutations consisting of small insertions and deletions in ELMO2 gene were reported in 5 families with a rare entity, the primary intraosseous vascular malformation or intraosseous hemangioma: VMOS (OMIM 606893). 8 The latter appears in early childhood, and is characterized by severe blood vessel expansions leading to painless swelling of the mandible, enlargement of facial bones, clavicles, ribs, and vertebrae with increased intracranial pressure, exophthalmos, spinal cord compression, all secondary to compression of organ compartments by the expanding vascular lesions. Supra-umbilical raphe, diastasis recti, and umbilical hernia can be seen as well. Chronic anemia due to repeated gingival bleeding episodes is seen.
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VMOS present many similarities with Ramon syndrome such as anemia, gingival bleeding, swelling of facial bones, or umbilical hernia. However, in the VMOS, there is no intellectual disability, no seizures, no short stature, no hypertrichosis, and no heart malformations. Furthermore, the vascular venous malformation that is characteristic of VMOS differs from the fibrous dysplasia observed in Ramon in which abundant cellular fibrous tissue between bone trabeculae is diagnostic 8 ( Table 1) . Moreover, these entities have an autosomal dominant mode of inheritance while Ramon syndrome is autosomal recessive.
We detected homozygous mutations in ELMO2 gene in patients with Ramon syndrome. ELMO2 forms a ternary complex with RhoG and DOCK180 to induce the activation of the GTPase RAC1, regulator of cytoskeleton dynamics and activator of a wide range of effector proteins. 10 The implication of ELMO2 in RAC1 regulation recalls the function of SOS1 as an activator of RAC1. In fact, SOS1 forms with 2 other proteins (EPS8 and E3B1) a complex that mediates the molecular switch of SOS1, directing its guanine nucleotide exchange factor activity toward the Rac1 signaling pathway.
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Among the DOCK proteins that interact with ELMO2, DOCK4 is an atypical guanine nucleotide exchange factor for Rac1, involved in the regulation of neurite differentiation. 12 Knockdown of DOCK4 was shown to reduce dendritic spine density, 13 which pathology is welldocumented in human disorders associated with intellectual disabilities and with a high prevalence of epilepsy. 14 Interestingly, the p.
I606S mutation herein detected is located in the atypical Pleckstrin homology domain of ELMO2 that is involved in the interaction with DOCK proteins. 15 At this moment it is not clear why the p.I606S mutation, should result in the complex phenotype of Ramon syndrome, when the previously reported loss of function changes in patients with VMOS appear to have only vascular abnormalities. It is tempting to speculate that some of the additional features in the patients with Ramon syndrome derive from a more complex effect of the mutation on RAC1 signaling possibly involving neural systems.
The report of additional cases with ELMO2 mutations is crucial to establish a better genotype phenotype correlation. Functional studies are also needed in order to understand the pathological mechanism.
